Vernikos-DanellisJ.: The Regulation of Synthesis and Release of ACTH in Vitamins and Hormones23: 97, Academic Press, New York, 1965.
2.
HaynesR. C., SutherlandE. W., RallT. W.: The Role of Cyclic Adenylic Acid in Hormone Action, Recent Progr. Hormone Res.16: 121–138, 1960.
3.
HilfR.: The Mechanism of Action of ACTH, N. E. J. Med.23: 798–811, 1965.
4.
Grahame-SmithD. G.: Adenosine 3′5′ Monophosphate as the Intracellular Mediator of the Action of Adrenocorticotrophin Hormones on the Adrenal Cortex, J. Biol. Chem.242: 5535–5541, 1967.
5.
ButcherR. W.: Role of Cyclic AMP in Cell Function, Advances in Biochemical Psychopharmacology3: 173–183, 1970.
6.
GarrenL. D., DavisW. E., CroccoR. M., MeyR. L.: Puromycin analogs: Action of Adrenocorticotrophic Hormone and the Role of Glycogen, Science152: 1386–1388 (June 3) 1966.
7.
FergusonJ. J.: Protein Synthesis and Adrenocorticotropin Responsiveness, J. Biol. Chem.235: 2754–2759, 1963.
8.
DavisW. W., GarrenL. D.: Evidence for the Stimulation by Adrenocorticotrophic Hormone of the Conversion of Cholesterol Esters to Cholesterol in the Adrenal, in Vivo, Biochem. Biophys. Res. Commun.22: 805–810, 1966.
9.
KaraboyasG. C., KoritzS. B.: Identity of the Site of Action of 3′,5′-Adenosine Monophosphate and Adrenocorticotrophic Hormone in Corticosteroidogenesis in Rat Adrenal and Beef Adrenal Cortex Slices, Biochem.4: 462–468 (Mar) 1965.
10.
LiddleG.W.: Clinical Application of a New Test of Pituitary Reserve, J. Clin. Endocrinol. Metabol.19: 875–894, 1959.
11.
American Hospital Formulary Service, published by the American Society of Hospital Pharmacists, Washington, D.C.
SundermanW.: Methodology of Corticosteroids and Aldosterone, Lipids and the Steroid Hormones in Clinical Medicine, Lippincott, Philadelphia, Pa.
15.
SparkRichard F.: Simplified Assessment of Pituitary-Adrenal Reserve, Ann. Intern. Med.75: 717–723, 1971.
16.
BuusO.: Metopirone Dosage in Pituitary Function Test, Lancet1: 1040 (May) 1962.
17.
GarbS.: Laboratory Tests in Common Use, Springer Publishing Co., Inc., New York, N.Y.1966.
18.
GarbS.: Undesirable Drug Interactions and Interferences, Springer Publishing Co., Inc., New York, N.Y.1971.
19.
FrohmanL. A.: Clinical Neuropharmacology of Hypothalmic Releasing Factors, N. E. J. Med.286: 1391–1396 (June 26) 1972.
20.
CryerP. E., and SodJ.: Drug Interference with Measurements of Adrenal Hormones in Urine: Analgesics and Tranquilizer-Sedatives, Ann. Intern. Med.75: 679, 1971.
21.
EisenmanA.J.: Urinary Excretion and Plasma Levels of 17-Hydroxycorticosteroids during a Cycle of Addiction to Morphine, J. Pharmacol. Exptl. Ther.132: 226, 1971.
22.
KuntzmanR.: Effect of Phenylbutazone on Cortical Metabolism in Man, Pharmacologist8: 195, 1966.
23.
ElliottH. C.: Reduced Adrenocortical Steroid Excretion Rates in Man Following Aspirin Administration, Metabolism11: 1015, 1962.
24.
HanstenP. D.: Drug Interactions, Lea and Febiger, Philadelphia, Pa., 1971.
25.
WerkE. E.Jr.: Failure of Metyrapone to Inhibit 11-Hydroxylation of 11-Deoxycortisol during Drug Therapy, J. Clin. Endo. Metabolism27: 1358, 1967.
26.
MeikleA.W.: Effect of Diphenylhydantoin on the Metabolism of Metyrapone and Release of ACTH in Man, J. Clin. Endo. Metabolism29: 1553, 1969.
27.
Cortrosyn—Official Package Brochure, Organon, Inc., West Orange. N.J. 07052